Factor Model (net -0.1)
Factor Model
net -0.1 1.0 / 10IM8 brand hits $120M ARR in first year
Watch: Watch whether IM8 can sustain ARR growth into Q1 2026 and how management deploys its $171 million cash pile — organic reinvestment or M&A will signal confidence in the model's staying power.
Prenetics Global posted a 480% revenue jump to $92.4 million in 2025, powered by its IM8 brand reaching $120 million in annual recurring revenue within a year of launch. Q4 revenue hit $36.6 million, up 55% from the prior quarter. The company sold its Insighta stake to Tencent for $70 million cash, leaving it with roughly $171 million in liquidity and zero debt.
The IM8 launch has transformed Prenetics from a COVID-testing relic into a recurring-revenue consumer health play with a clean balance sheet. Sequential acceleration in Q4 and strong ARR suggest the brand has real traction, while the Tencent exit gives management dry powder to scale without dilution risk.
Evidence
Fundamentals & Data ▾
Get alerted when PRE changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.